Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients Who Are Unsuitable for Full-Dose Fludarabine-Based Therapy
Ana Teresa Paquete, Luis Silva Miguel, Ursula Becker, Catarina Pereira, Carlos Gouveia Pinto
Applied Health Economics And Health Policy, vol. 15, 2017, p. 501-512.